MicroRNA-488-3p-loaded engineered exosomes inhibit proliferation, migration and invasion of hepatocellular carcinoma...

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Hepatocellular carcinoma (HCC) is a prevalent malignancy worldwide.
• SEC61G acts as an oncogene in HCC development.
• Effective microRNA (miRNA) delivery for cancer therapy remains a significant challenge.

Purpose of the Study:

• To investigate the therapeutic potential of miRNA-loaded engineered exosomes in HCC.
• To identify specific miRNAs targeting the SEC61G oncogene.
• To evaluate the efficacy of engineered exosomes delivering miR-488-3p in HCC cells.

Main Methods:

• Bioinformatic screening (Targetscan) and cell-based assays to identify miRNAs targeting SEC61G.
• Dual-luciferase reporter assay to confirm target interaction.
• Isolation and characterization of engineered exosomes loaded with miR-488-3p (Exo-miR-488-3p) using nanoparticle tracking analysis, transmission electron microscopy, and western blot.
• In vitro assessment of Exo-miR-488-3p effects on HCC cell proliferation, colony formation, migration, invasion, and apoptosis.

Main Results:

• miR-488-3p was identified as a direct inhibitor of SEC61G in HCC cells.
• Engineered exosomes (Exo-miR-488-3p) successfully delivered miR-488-3p into HCC cells.
• Exo-miR-488-3p significantly suppressed HCC cell proliferation, colony formation, migration, and invasion.
• A trend towards increased apoptosis was observed, although not statistically significant.

Conclusions:

• Engineered exosomes loaded with miR-488-3p demonstrate significant potential in inhibiting malignant activities of HCC cells.
• Exo-miR-488-3p represents a viable strategy for targeted miRNA delivery in HCC treatment.
• Further research is warranted to explore the therapeutic application of Exo-miR-488-3p in HCC.